Donepezil Hydrochloride Tablets 5mg (Donepezil Hydrochloride Tablets “KUNIHIRO”® / ドネペジル塩酸塩錠5mg「クニヒロ」)

JPY ¥4,000

Japanese Alzheimer’s Type and Lewy Body Dementia Treatment Agent (Donepezil Hydrochloride 5mg). Oral tablet for suppression of progression of dementia symptoms. 56 tablets (PTP: 14 tablets x 4). Mfd. by Kokando Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥3,680
10 - 19 12% JPY ¥3,520
20 + 18% JPY ¥3,280
SKU: DON-5-TAB Category:

Description

Product Overview / 商品概要

Donepezil Hydrochloride Tablets 5mg “KUNIHIRO” (ドネペジル塩酸塩錠5mg「クニヒロ」)
Generic: Donepezil Hydrochloride / ドネペジル塩酸塩
Therapeutic Category: Alzheimer’s Type and Lewy Body Dementia Treatment Agent / アルツハイマー型、レビー小体型認知症治療剤
Manufactured by: Kokando Pharmaceutical Co., Ltd. / 皇漢堂製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Donepezil Hydrochloride (Japanese Pharmacopoeia) 5mg per tablet / 日本薬局方 ドネペジル塩酸塩 5mg(1錠中)
Additives: Lactose hydrate, Microcrystalline cellulose, Corn starch, Hydroxypropylcellulose, Magnesium stearate, Hypromellose, Macrogol 6000, Talc, Titanium oxide / 乳糖水和物、結晶セルロース、トウモロコシデンプン、ヒドロキシプロピルセルロース、ステアリン酸マグネシウム、ヒプロメロース、マクロゴール6000、タルク、酸化チタン
Appearance: White film-coated tablet, diameter 7.1mm, thickness 3.7mm, weight 143mg, identification code: KS352
外観: 白色のフィルムコーティング錠、直径7.1mm、厚さ3.7mm、重量143mg、識別コード:KS352

Indications / 効能効果

EN: Suppression of progression of dementia symptoms in Alzheimer’s disease and Lewy body dementia
JA: アルツハイマー型認知症及びレビー小体型認知症における認知症症状の進行抑制

Dosage and Administration / 用法用量

EN: Usually, adults begin with 3mg of donepezil hydrochloride once daily, increasing to 5mg after 1 to 2 weeks, administered orally. For patients with severe Alzheimer’s disease, the dose may be increased to 10mg after at least 4 weeks at 5mg. Dosage may be reduced as appropriate based on symptoms. Usually, adults begin with 3mg of donepezil hydrochloride once daily, increasing to 5mg after 1 to 2 weeks, administered orally. After at least 4 weeks at 5mg, the dose may be increased to 10mg. Dosage may be reduced to 5mg based on symptoms.
JA: 〈アルツハイマー型認知症における認知症症状の進行抑制〉通常、成人にはドネペジル塩酸塩として1日1回3mgから開始し、1~2週間後に5mgに増量し、経口投与する。高度のアルツハイマー型認知症患者には、5mgで4週間以上経過後、10mgに増量する。なお、症状により適宜減量する。〈レビー小体型認知症における認知症症状の進行抑制〉通常、成人にはドネペジル塩酸塩として1日1回3mgから開始し、1~2週間後に5mgに増量し、経口投与する。5mgで4週間以上経過後、10mgに増量する。なお、症状により5mgまで減量できる。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product or piperidine derivatives
JA: 本剤の成分又はピペリジン誘導体に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22400AMX00353000
Sales Started: June 2017 / 2017年6月
Classification Code: 87119
Storage: Store at room temperature / 室温保存
Shelf Life: —

Packaging / 包装

Main Package (for sale): 56 tablets (PTP: 14 tablets x 4) / 56錠(PTP:14錠×4)
Other Available Packages (by special order): 56 tablets (PTP: 14 tablets x 4), 140 tablets (PTP: 14 tablets x 10), 100 tablets (bottle: bulk)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Donepezil Hydrochloride Tablets 5mg (Donepezil Hydrochloride Tablets “KUNIHIRO”® / ドネペジル塩酸塩錠5mg「クニヒロ」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Donepezil Hydrochloride Tablets 5mg (Donepezil Hydrochloride Tablets "KUNIHIRO"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.